Comparative purification and characterization of hepatitis B virus-like particles produced by recombinant vaccinia viruses in human hepatoma cells and human primary hepatocytes

PLoS One. 2019 Feb 22;14(2):e0212800. doi: 10.1371/journal.pone.0212800. eCollection 2019.

Abstract

This study describes the comparative expression and purification of hepatitis B surface antigen (HBsAg) particles produced upon infection of human primary hepatocytes and human hepatoma cell lines (HuH-7 and HepG2) with recombinant vaccinia viruses. The highest levels of HBsAg expression were found in HuH-7 hepatoma cells following infection with recombinant vaccinia viruses, which contain the S gene under control of a 7.5 k-promoter. Four different methods for purification of the HBsAg particles were examined: isopycnic ultracentrifugation, sucrose cushion sedimentation, isocratic column gel filtration, and binding to anti-HBs-coated microparticles. The highest degree of purity of HBsAg particles was reached by the method based on anti-HBs-coated microparticles. The resulting product was >98% pure. Biochemical analysis and characterization of purified HBsAg particles were performed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), western blotting, and electron microscopy. The HBsAg, purified from human hepatoma cell lines and from human primary hepatocytes, consisted of both the non-glycosylated (p25) and the glycosylated (gp27) form and assembled into typical 22-nm particles, and thus may be of great interest and importance for research, diagnostics, and medical treatments.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Hepatocellular / genetics
  • Carcinoma, Hepatocellular / metabolism*
  • Cell Line, Tumor
  • Chromobox Protein Homolog 5
  • Glycosylation
  • Hepatitis B Surface Antigens* / biosynthesis
  • Hepatitis B Surface Antigens* / chemistry
  • Hepatitis B Surface Antigens* / genetics
  • Hepatitis B Surface Antigens* / isolation & purification
  • Hepatitis B virus / genetics*
  • Hepatitis B virus / metabolism
  • Hepatocytes / metabolism*
  • Humans
  • Liver Neoplasms / genetics
  • Liver Neoplasms / metabolism*
  • Particle Size
  • Vaccines, Virus-Like Particle* / chemistry
  • Vaccines, Virus-Like Particle* / genetics
  • Vaccines, Virus-Like Particle* / isolation & purification
  • Vaccines, Virus-Like Particle* / metabolism
  • Vaccinia virus / genetics*
  • Vaccinia virus / metabolism

Substances

  • CBX5 protein, human
  • Hepatitis B Surface Antigens
  • Vaccines, Virus-Like Particle
  • Chromobox Protein Homolog 5

Grants and funding

This work was supported by institutional research funds of the University of Regensburg to WJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.